7.29 (-%)
As of Oct 31, 2024
Source:
Adverum Biotechnologies, Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. We discover and develop gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein.
Country | United States |
Headquarters | redwood city, california |
Phone Number | (650) 656-9323 |
Industry | manufacturing |
CEO | Laurent Fischer |
Website | www.adverum.com |